O'Keefe Kenneth W 4
4 · Jazz Pharmaceuticals plc · Filed Nov 4, 2020
Insider Transaction Report
Form 4
O'Keefe Kenneth W
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2020-11-02+22,249→ 29,667 total - Exercise/Conversion
Phantom Stock
2020-11-02−22,249→ 0 totalFrom: 2020-11-02Exp: 2020-11-02→ Ordinary Shares (22,249 underlying)
Holdings
- 4,445(indirect: By Trust)
Ordinary Shares
Footnotes (2)
- [F1]On November 2, 2020, the Reporting Person's 22,249 phantom stock rights under the Issuer's Amended and Restated Directors Deferred Compensation Plan were settled for an equal number of the Issuer's ordinary shares.
- [F2]Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.